5′-Azacitidine in myelodysplastic syndromes with inversion of chromosome 3

被引：3

作者：

Breccia, M. ^{[1
]}

Cannella, L. ^{[1
]}

Santopietro, M. ^{[1
]}

Loglisci, G. ^{[1
]}

Federico, V. ^{[1
]}

Salaroli, A. ^{[1
]}

Nanni, M. ^{[1
]}

Mancini, M. ^{[1
]}

Alimena, G. ^{[1
]}

机构：

[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy

来源：

LEUKEMIA | 2011年 / 25卷 / 04期

关键词：

AZACITIDINE; LEUKEMIA;

D O I：

10.1038/leu.2011.6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：736 / 737

页数：3

共 6 条

[1]

FEANUX P, 2009, LEUKEMIA RES, V33, pS7

[2] Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study [J].

Fenaux, Pierre ;

Mufti, Ghulam J. ;

Hellstrom-Lindberg, Eva ;

Santini, Valeria ;

Finelli, Carlo ;

Giagounidis, Aristoteles ;

Schoch, Robert ;

Gattermann, Norbert ;

Sanz, Guillermo ;

List, Alan ;

Gore, Steven D. ;

Seymour, John F. ;

Bennett, John M. ;

Byrd, John ;

Backstrom, Jay ;

Zimmerman, Linda ;

McKenzie, David ;

Beach, C. L. ;

Silverman, Lewis R. .

LANCET ONCOLOGY, 2009, 10 (03) :223-232

[3] Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine [J].

Itzykson, Raphael ;

Thepot, Sylvain ;

Quesnel, Bruno ;

Dreyfus, Francois ;

Beyne-Rauzy, Odile ;

Turlure, Pascal ;

Vey, Norbert ;

Recher, Christian ;

Dartigeas, Caroline ;

Legros, Laurence ;

Delaunay, Jacques ;

Salanoubat, Celia ;

Visanica, Sorin ;

Stamatoullas, Aspasia ;

Isnard, Francoise ;

Marfaing-Koka, Anne ;

de Botton, Stephane ;

Chelghoum, Youcef ;

Taksin, Anne-Laure ;

Plantier, Isabelle ;

Ame, Shanti ;

Boehrer, Simone ;

Gardin, Claude ;

Beach, C. L. ;

Ades, Lionel ;

Fenaux, Pierre .

BLOOD, 2011, 117 (02) :403-411

[4] The EVI1 gene in myeloid leukemia [J].

Nucifora, G .

LEUKEMIA, 1997, 11 (12) :2022-2031

[5] EVII is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangements [J].

Poppe, B ;

Dastugue, N ;

Vandesompele, J ;

Cauwelier, B ;

De Smet, B ;

Yigit, N ;

De Paepe, A ;

Cervera, J ;

Recher, C ;

De Mas, V ;

Hagemeijer, A ;

Speleman, F .

GENES CHROMOSOMES & CANCER, 2006, 45 (04) :349-356

[6] Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B [J].

Silverman, LR ;

Demakos, EP ;

Peterson, BL ;

Kornblith, AB ;

Holland, JC ;

Odchimar-Reissig, R ;

Stone, RM ;

Nelson, D ;

Powell, BL ;

DeCastro, CM ;

Ellerton, J ;

Larson, RA ;

Schiffer, CA ;

Holland, JF .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) :2429-2440

← 1 →